SUMMARY Recent studies suggest that phospholipid-sensitive, Ca 2+ -dependent protein kinase C participates in contractile responses of vascular smooth muscle. This study characterizes vascular reactivity to protein kinase C activators in stroke-prone spontaneously hypertensive rats (SHRSP) and normotensive Wistar-Kyoto rats (WKY). Helical strips of mesenteric arteries were mounted in organ chambers for measurement of isometric contractions (responses were normalized as a percentage of maximal force in response to 100 mM KC1; in SHRSP, 350 ± 16 mg; in WKY, 335 ± 21 ing). Arteries from SHRSP contracted faster and developed greater force than arteries from WKY (168 ± 9% vs 143 ± 3%) in response to the phorbol ester, 12-Otetradecanoylphorbol-13-acetate. Arteries from SHRSP (0.6 x 10-8 M) were more sensitive to the phorbol ester than those from WKY (2.2 x 1(H M), as indicated by the dose of the phorbol ester required to produce 50% of the maximal response to KC1. Additionally, SHRSP arteries were more sensitive to the contractile effects of mezerein, a non-phorbol ester activator of protein kinase C. Ca 2+ -free solution (1.0 mM EGTA) and verapamil (10-7 M) caused relaxation (approximately -60%) of contractions in response to the phorbol ester (10-* M). Addition of 10-6 M of the phorbol ester to arteries that were preincubated in Ca 2+ -free solution (1.0 mM EGTA for 30 minutes) elicited submaximal contractions (in SHRSP, 26 ± 4%; in WKY, 38 ± 7%). Upon addition of 1.6 mM Ca 2+ , arteries from SHRSP contracted faster (t^, =2.7 ± 0.6 minutes) than those from WKY (8.2 ± 0.5 minutes). These data indicate that increased vascular responsiveness in SHRSP may result from enhanced activity of the protein kinase C branch of the Ca 2+ messenger system. (Hypertension 9 [Suppl III]: IIM50- III-154, 1987) KEY WORDS • stroke-prone spontaneously hypertensive rats • mesenteric artery • protein kinase C • phorbol ester K CENT evidence suggests that in vascular smooth muscle, phosphatidylinositol 4,5-bisphosphate of the plasma membrane is hydrolyzed by phospholipase C in response to certain hormones and neurotransmitters. '-5 A product of this hydrolysis, inositol 1,4,5-trisphosphate, has been proposed to be a messenger for Ca 2+ release from intracellular stores.
K
CENT evidence suggests that in vascular smooth muscle, phosphatidylinositol 4,5-bisphosphate of the plasma membrane is hydrolyzed by phospholipase C in response to certain hormones and neurotransmitters.'- 5 A product of this hydrolysis, inositol 1,4,5-trisphosphate, has been proposed to be a messenger for Ca 2+ release from intracellular stores. 6 -7 Furthermore, Nishizuka 8 has shown that another product of phosphatidylinositol turnover, diacylglycerol, can activate protein kinase C (C-kinase). Diacylglycerol, along with phosphatidylserine, greatly increases the affinity of C-kinase for Ca 2+ to the submicromolar range, thereby rendering this enzyme fully active. 9 Kojima et al. 10 have suggested that C-kinase provides a gain control in the Ca 2+ -messenger system, allowing for a near-maximal response at less than maximal levels of Ca 2+ messenger input. Tumor-promoting phorbol esters, such as 12-0-tetradecanoylphorbol-13-acetate (TPA), have been used to study the cellular functions of C-kinase. Castagna et al." have shown that TPA directly activates purified C-kinase in vitro. Numerous studies provide evidence indicating that TPA may be inserted into cell membranes and that it directly activates C-kinase.' '~1 4 Other studies have demonstrated that TPA causes platelet aggregation," 12 smooth muscle myosin light chain phosphorylation, 15 and vascular smooth muscle contraction. 16 "
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neously hypertensive rats (SHRSP) and normotensive Wistar-Kyoto rats (WKY) in order to gain information about contractile mechanisms that may relate to C-kinase activation.
Materials and Methods
The SHRSP and WKY were obtained from a colony in the Department of Anatomy and Cell Biology at The University of Michigan. The colony was derived from a stock supplied by the National Institutes of Health, Bethesda, MD. Rats were 4 to 6 months of age at the time of experimentation. Systolic blood pressures were measured in the conscious state by a tail cuff method (pneumatic transducer).
Tissue Preparation
Rats were anesthetized with sodium pentobarbital (50 mg/kg). Mesenteric arteries were excised, and placed in a cold physiological salt solution (PSS) of the following composition (in raM): NaCl, 130; KC1, 4.7; KH 2 PO 4 , 1.18; MgSO 4 -7H 2 O, 1.17; CaCl 2 -2H 2 O, 1.6; NaHCO 3 , 14.9; dextrose, 5.5; and CaNvEDTA, 0.03. Mesenteric arteries were cut into helical strips (1 mm x 5 mm), which were mounted on stationary metal bases and suspended in a 50-ml tissue bath filled with PSS, maintained at 37°C, and aerated with 95% O 2 , 5% CO 2 . Arterial segments were attached to force transducers (Model FT.03, Grass, Quincy, MA, USA) for measurement of isometric force (recorded on Grass polygraphs). A constant passive force of 500 mg was applied to each vascular strip. This level of passive force yields maximal active contractions when the strip is stimulated with either norepinephrine or a depolarizing solution. 20 A 90-minute equilibration period preceded each experiment.
Experimental Protocol
Four vascular responses to C-kinase activators were examined: 1) time course of contraction in response to 10" 6 M TPA (60 minutes); 2) cumulative doseresponse curves in response to TPA (lO^-lO" 6 M) and mezerein (10~'°-10~* M); 10-minute intervals were allowed between additions of drug concentrations; 3) relaxation of TPA-induced contractions by Ca 2+ -free, 1.0 mM EGTA PSS (10 minutes) and by 10" 7 M verapamil (20 minutes); and 4) TPA-induced contractions in the absence of Ca 2+ (30 minutes) and subsequent addition of 1.6 mM Ca 2+ . Contractions are normalized as a percentage of maximal isometric force generated in response to 100 mM KC1. Vascular sensitivity to the phorbol esters was defined as the dose that produced a contractile response that was 50% of the maximal response to KC1 (EC,,, KC1). These values were estimated from graphic representation of the individual doseresponse curves. This procedure was necessary, since the contractile responses to the phorbol esters were slow, and full dose-response relationships could only be evaluated using short intervals between drug additions (10 minutes). Thus, maximal responses to the phorbol esters were not attained over the dose range tested.
Statistical Analysis
Data are reported as means ± standard error of the mean (SEM). Statistical comparisons between rat groups were performed by Student's t test. A p value of 0.05 was the criterion for statistical significance.
Drugs
TPA, mezerein, and the biologically inactive phorbol 12-myristate 13-acetate 4-O-methyl ether (Sigma, St. Louis, MO, USA) were dissolved in dimethyl sulfoxide to give stock solutions of 1.0 mM. Verapamil (Sigma) was dissolved in ethanol to yield a stock solution of 0.1 mM. All other chemicals were of reagent grade (Sigma).
Results
Systolic blood pressures of SHRSP (216 ± 5 mm Hg; n = 14) were significantly higher than those of WKY (119 ± 3 mm Hg; n= 12). Body weights of SHRSP (303 ± 10 g) did not differ from those of WKY (330 ± 7 g).
Force Development in Response to Depolarizing Solution
In all experiments, the arterial strips were made to contract in response to depolarizing solution (100 mM KC1) to determine whether force development to this stimulus differed between the two rat groups. Contractile responses to 100 mM KC1 in SHRSP arteries (350 ± 16 mg; n = 22) did not differ from those in WKY arteries (335 ± 21 mg; n = 21).
Contractile Responses to TPA and Mezerein
Addition of 10" 6 M TPA to the organ bath elicited contractions in arteries from SHRSP and WKY ( Figure  1 ). The rate of force development was slow relative to that in response to 100 mM KC1 (see Figure 3) . SHRSP arteries contracted faster in response to TPA than WKY arteries, as indicted by the time required to reach a half-maximal response to TPA ( V SHRSP, 12 ± 0.9 minutes; WKY, 15 ± 0.8 minutes; p < 0.05). Figure 2 ; values for both groups of rats are plotted together).
Calcium and Contractile Responses to TPA
Contractile responses to 10" 6 M TPA were inhibited by the Ca 2+ channel blocker verapamil (10~7 M; Figure  3 ). In these experiments, the contractile responses to 10" 6 M TPA were allowed to reach a plateau before addition of verapamil. The inhibitory action of the Ca 2+ channel blocker was quantitated as a percentage of this contraction. The inhibitory action of verapamil on TPA-induced contractions was greater in SHRSP arteries ( -68 ± 4%; n = 6,p< 0.05) than in WKY arteries ( -52 ± 4%; n = 6). Replacement of the PSS during a TPA-induced contraction with a Ca 2+ -free PSS containing 1.0 mM EGTA also caused relaxation in SHRSP and WKY arteries. In contrast to the experiments with verapamil, the inhibitory effect of Ca 2+ -free treatment in SHRSP arteries ( -57 ± 5%; n = 7) did not differ significantly from that in WKY arteries ( -4 7 ±6%; n = 7).
Since the contractile responses to TPA were not inhibited completely by Ca 2+ -free solution, further experiments were performed to evaluate the Ca 2+ dependency of these contractions (Figures 4 and 5) . Arteries from SHRSP and WKY were placed in Ca 2+ -free solution containing 1.0 mM EGTA for 60 minutes. Fifteen minutes into this interval, the arterial strips were stimulated with norepinephrine (3 X 10" 8 M) for 5 minutes in order to unload intracellular stores of Ca 2+ . 21 The norepinephrine was rinsed from the bath, and incubation in the Ca -free, 1.0 mM EGTA solution, the arteries were placed in normal PSS (1.6 mM Ca 2+ ) containing 10" 6 M TPA. Arteries from both groups of rats contracted in response to this Ca 2+ addition; the rate of force development was faster in SHRSP arteries than in WKY arteries (see Figure 5 , right panel). The same protocol (described in Figure 4 ) for evaluating the Ca 2+ dependency of TPA-induced contractions was repeated using 100 mM KC1 as the agonist. In these experiments, SHRSP and WKY arteries did not contract in response to KC1 following norepinephrine treatment in Ca 2+ -free, 1.0 mM EGTA solution. Upon readdition of 1.6 mM Ca 2+ (with 100 mM KC1), the arteries from both groups of rats contracted. In contrast to the TPA-induced responses, time to halfmaximal contraction for 100 mM KC1 in SHRSP arteries (t w = 0.3 ± 0.1 minutes; n = 5) did not differ from that in WKY arteries (0.3 ± 0.1 minutes; n = 5).
Discussion
Extensive observations have been reported that indicate that vascular reactivity in SHRSP is greater than that in WKY. 22 The current study dissects the sequence of cellular events leading to contraction in order to localize a component of the sequence that could account for the increased vascular reactivity in hypertension. This study demonstrates that mesenteric arteries from SHRSP are more responsive than those from WKY to the contractile effects of C-kinase activators (TPA and mezerein).
In order to determine if the vascular responses to TPA were nonspecific phorbol ester effects, vascular reactivity to mezerein and a biologically inactive phorbol ester was also examined. Mezerein, a non-phorbol ester activator of protein kinase C, 23 elicited significantly greater contractions in SHRSP than in WKY. Furthermore, the inactive phorbol ester did not cause contractions in arteries from either group of rats. Thus, it seems likely that the vascular responses to TPA are mediated by C-kinase activation. Final proof of Ckinase activation in this study requires measurement of enzyme activity. However, there are many studies demonstrating that the phorbol ester receptor and Ckinase are the same protein.
14 ' 24~26 Thus, these observations are consistent with the hypothesis that increased vascular reactivity in SHRSP is the result of enhanced activity of the C-kinase branch of the Ca 2+ messenger system.
There are several possible explanations for the enhanced vascular reactivity to C-kinase activators in SHRSP: 1) the amount or turnover rate of the enzyme and/or the affinity of the enzyme for TPA and mezerein may be increased; 2) the C-kinase activators may increase Ca 2+ sensitivity of the enzyme to a greater extent; 3) the cytoplasmic Ca 2+ concentrations and/or transmembrane Ca 2+ fluxes may be increased; 4) the availability of membrane phospholipids (i.e., phosphatidylserine, an accomplice to C-kinase activation) may be increased; and/or 5) cellular events that occur subsequent to C-kinase activation may be augmented. The current experiments do not differentiate among these possible mechanisms.
A large portion of the contractile response to TPA is dependent upon extracellular Ca 2+ . Ca 2+ -free solution containing EGTA and verapamil caused relaxation of contractions due to TPA (see Figure 3) . Relaxation in response to verapamil was greater in SHRSP, but relaxation in SHRSP arteries in response to Ca 2+ -free solution did not differ from that in WKY arteries. The significance of this difference between responses to verapamil and Ca 2+ -free solution is unknown, but the action of verapamil may be somewhat nonspecific. It has been observed that this drug competitively inhibits phospholipid interactions 27 in addition to blocking Ca 2+ channels.
Further evidence supporting the Ca 2+ dependency of contractions in response to phorbol esters was that the readdition of Ca 2+ caused contraction in arteries treated with TPA in Ca 2+ -free solution. SHRSP arteries contracted at a faster rate than WKY arteries upon readdition of Ca 2+ , suggesting that there is an alteration in the way in which Ca 2+ and the phorbol esters interact with C-kinase to produce contraction in SHRSP. The abnormality is probably complex, since Ca 2+ interacts in at least three different levels in the events that lead to contraction in vascular smooth muscle: 1) Ca 2+ , along with diacylglycerol and phosphatidylserine, activates the C-kinase; 2) Ca 2+ activates calmodulin, which results in myosin light chain phos-Ill-154 phorylation; and 3) Ca 2+ is a regulator of other enzymes and plays a role in the regulation of membrane permeability.
An interesting observation of this study is that Ckinase activation with TPA caused contraction in arteries from SHRSP and WKY in Ca 2+ -free solution containing EGTA. This response was not mimicked by depolarizing solution, and it suggests that C-kinase activation promotes contraction at very low levels of intracellular Ca 2+ . Recent work in several cell systems supports this conclusion. The major observation is that the phorbol esters greatly enhance the affinity of Ckinase for Ca 2+ . 28 Thus, it seems that the Ca
2+
-free EGTA incubation sufficiently chelated free Ca 2+ to inhibit contraction in response to norepinephrine and 100 mM KC1, but the incubation procedure was ineffective in completely preventing activation of the enzyme. Nonetheless, the extent of TPA-induced contractions of SHRSP arteries under these conditions did not differ from that in WKY arteries.
In summary, these experiments demonstrate an augmented vascular reactivity to C-kinase activators in mesenteric arteries from SHRSP. The augmentation may be a result of an enhanced activity of the Ca 2+ , phospholipid-dependent protein kinase C in vascular smooth muscle of SHRSP. This abnormality may underlie increased vascular responsiveness to various hormones and neurotransmitters that utilize this Ca 2+ -dependent regulatory mechanism in causing contraction.
